Bausch Health Companies Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $2.40B | $-2.41B | $-288.0M | $880.0M | $-863.6M | $-116.0M | $159.6M | $366.7M |
| Depreciation & Amortization | $2.86B | $2.87B | $2.47B | $1.61B | $2.02B | $986.2M | $612.6M | $254.5M |
| Depreciation | $168.0M | $193.0M | $210.0M | $187.0M | $114.0M | $54.8M | $45.6M | $23.9M |
| Amortization | — | — | — | — | $1.90B | $931.4M | $567.0M | $228.9M |
| Stock-Based Compensation | $87.0M | $165.0M | $140.0M | $78.0M | $45.5M | $66.2M | $94.0M | $98.0M |
| Net Cash from Operating Activities | $2.29B | $2.09B | $2.26B | $2.31B | $1.04B | $656.6M | $640.5M | $263.2M |
| Investing Activities | ||||||||
| Capital Expenditures | $171.0M | $235.0M | $235.0M | $292.0M | $115.3M | $107.6M | $58.5M | $16.8M |
| Business Acquisitions | $0 | $19.0M | $15.46B | $1.10B | $5.25B | $3.49B | $2.46B | $-309.0M |
| Net Cash from Investing Activities | $2.89B | $-125.0M | $-15.58B | $-100.0M | $-5.38B | $-2.97B | — | $228.9M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | $356.3M |
| Stock Repurchases | $0 | $0 | $72.0M | $0 | $55.6M | $280.7M | $639.2M | $60.1M |
| Net Cash from Financing Activities | $-4.96B | $-1.96B | $13.62B | $-2.46B | $4.03B | $3.06B | — | $-213.3M |
| Net Change in Cash | $255.0M | $-55.0M | $274.0M | — | — | — | — | $279.8M |
| Free Cash Flow | $2.12B | $1.85B | $2.02B | $2.02B | $926.7M | $549.0M | $582.0M | $246.4M |